Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL) Stock Price, News & Analysis

Company Overview

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. the mission of the company is to exploit advances over the past decade in the understanding of glutamate mechanisms involved in a variety of diseases. the company's first drug candidate is being developed for orphan neurological disorders as well as treatment-resistant anxiety and depression. biohaven has assembled a team of experts who have extensive experience in the development of therapeutic agents in this area and also comprise the originators at yale university who discovered the therapeutic potential of glutamate modulation in anxiety and depression. team members have designed and executed successful development programs t

Key Stats

• Today's Range: $17.89 to $18.16
• 50-Day Range: $18.00 to $20.34
• 52-Week Range: $17.49 to $20.85
• Volume: 14,450 shs
• Average Volume: 22,335 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CGABL Stock Analysis - Frequently Asked Questions

How have CGABL shares performed this year?

Carlyle Group Inc. 4.625% Subordinated Notes due 2061's stock was trading at $20.59 on January 1st, 2024. Since then, CGABL shares have decreased by 11.9% and is now trading at $18.13.
View the best growth stocks for 2024 here.

How do I buy shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061?

Shares of CGABL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 11/15 Dividend: 11/01/2024
• Dividend Payable: 11/15/2024
• Today: 12/22/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: --
• Industry: -
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CGABL
• CUSIP: N/A
• CIK: 1527166
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: 686
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A